Articles

Eli Lilly Articles

June 16, 2021PharmaTimesNews

Lilly plans head-to-head migraine study comparing Emgality with Nurtec ODT

The primary endpoint of the study is a 50% reduction in monthly migraine headache days... See more »
June 16, 2021FinSMEs News

Circle Pharma Raises $66M in Series C Financing

Circle Pharma, Inc., a South San Francisco,...... See more »
June 16, 2021Korea Biomedical ReviewNews

Lilly's Olumiant proves fast symptom improvement in atopic dermatitis

Eli Lilly's Olumiant (ingredient: baricitinib), the first Janus kinase (JAK) inhibitor to win approva... See more »
June 16, 2021FiercePharmaNews

Boehringer, Lilly and Takeda join matchmaker PharmStars' digital health accelerator

Boehringer, Lilly and Takeda join matchmaker PharmStars' digital health accelerator bbulik Tue, 06/15... See more »
June 15, 2021FinSMEs News

VectorY Raises 31M in Seed Funding

VictorY, an Amsterdam, The Netherlands-based...... See more »
June 15, 2021BioSpaceNews

Lilly Launches Head-to-Head Trial in Quest to Bolster Migraine Preventive Drug

Eli Lilly and Company announced Tuesday the launch of a head-to-head study to compare once-monthly in... See more »
June 14, 2021MarketScreenerNews

Lilly to Participate in Guggenheim Biopharma Strategy Series

(marketscreener.com) INDIANAPOLIS, June 14, 2021 /PRNewswire/ -- Eli Lilly and Company will participa... See more »
June 13, 2021Markets InsiderNews

Lilly announces new clinical data from Verzenio and oral SERD programs at the American Society of Clinical Oncology annual meeting

New exploratory analysis of a pre-specified subgroup of patients with HR+, HER2- high risk early brea... See more »
June 11, 2021One America News NetworkNews

Eli Lilly memo says firm did not make false statements to FDA

June 10, 2021 version="1.0″ encoding="utf-8″ standalone="yes"?>... See more »
June 11, 2021Markets InsiderNews

Lilly Announces Webcast to Provide Diabetes Portfolio Update at ADA

INDIANAPOLIS, June 11, 2021 /PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) will host a webcast on ... See more »
June 4, 2021PR NewswirePress Release

Lilly Announces New Clinical Data from Verzenio and Oral SERD Programs at the American Society of Clinical Oncology Annual Meeting

INDIANAPOLIS, June 4, 2021 /PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) today announced new data... See more »
June 1, 2021Eli Lilly Youtube ChannelVideo

"Lilly - A Medicine Company (:90 version)" on YOUTUBE

June 1, 2021StreetInsiderPress Release

OLUMIANT Improved Pain, Physical Function and Morning Joint Stiffness in Rheumatoid Arthritis in Phase 3 Post-Hoc Analyses

INDIANAPOLIS, June 1, 2021 /PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) and Incyte (NASDAQ: INCY... See more »
May 28, 2021Eli Lilly Youtube ChannelVideo

"Engineering Careers at Lilly" on YOUTUBE

May 21, 2021Business WirePress Release

CHMP issues positive opinion for Jardiance (empagliflozin) for the treatment of adults with heart failure with reduced ejection fraction

INGELHEIM, Germany--(BUSINESS WIRE)--CHMP issues positive opinion for Jardiance® (empagliflozin) for ... See more »
May 19, 2021PR NewswirePress Release

Lilly Announces Details of Presentations at 2021 American Society of Clinical Oncology (ASCO) Annual Meeting

INDIANAPOLIS, May 19, 2021 /PRNewswire/ -- New data from across Eli Lilly and Company's (NYSE: LLY) o... See more »
April 23, 2021StreetInsiderPress Release

Taltz Delivers More Cumulative Days with Completely Clear Skin for Adults with Psoriasis Compared to Seven Other Biologics in Novel Network Meta-Analysis

INDIANAPOLIS, April 23, 2021 /PRNewswire/ -- Through clinical trial meta-analysis and real-world evid... See more »
April 21, 2021Cision CanadaPress Release

Eli Lilly is the most innovative company for the first time

/CNW/ -- The tenth annual Pharmaceutical Innovation Index, released today, sees Eli Lilly top the ind... See more »
April 20, 2021Cision CanadaPress Release

Lilly Presents New Data on selpercatinib in Advanced RET Fusion-Positive Gastrointestinal and Other Cancers at 2021 American Association for Cancer Research (AACR) Annual Meeting

/CNW/ - On April 11, 2021, Eli Lilly and Company announced data from the Phase 1/2 LIBRETTO-001 trial... See more »
April 16, 2021Cision CanadaPress Release

Lilly and Incyte announce results from the Phase 3 COV-BARRIER study of baricitinib in hospitalized COVID-19 patients

/CNW/ - On April 8, 2021, Eli Lilly and Company and Incyte announced the results of COV-BARRIER, a Ph... See more »
April 1, 2021PR NewswirePress Release

Lilly to Host Sustainability Webcast to Provide Overview of Environmental, Social and Governance (ESG) Efforts

INDIANAPOLIS, April 1, 2021 /PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) will host a webcast for... See more »
March 29, 2021PR NewswirePress Release

Lilly, Vir Biotechnology and GSK Announce Positive Topline Data from the Phase 2 BLAZE-4 Trial Evaluating Bamlanivimab with VIR-7831 in Low-Risk Adults with COVID-19

INDIANAPOLIS and SAN FRANCISCO and LONDON, March 29, 2021 /PRNewswire/ -- Eli Lilly and Company (NYSE... See more »
March 19, 2021Eli Lilly Youtube ChannelVideo

"Metastatic Breast Cancer: Christine's Story" on YOUTUBE

March 19, 2021Eli Lilly Youtube ChannelVideo

"Alzheimer's Disease: Bob's Story" on YOUTUBE

March 19, 2021Eli Lilly Youtube ChannelVideo

"The COVID-19 Pandemic: Janelle's Story" on YOUTUBE

March 18, 2021Eli Lilly Youtube ChannelVideo

"The History Of Insulin: Marissa's Story" on YOUTUBE

April 28, 2015LILLY BLOGBlog

Embracing the Power of Diversity

April 22, 2015LILLY BLOGBlog

Keep Calm and Recycle On

Loading interface...
Loading interface...
Loading interface...
Loading interface...